Personas / Equipo Humano

Manuel Vázquez Carrera

Buscador de publicaciones

Publicaciones

  • Aguilar-Recarte D, Barroso E, Palomer FX, Wahli W and Vazquez M.

    Knocking on GDF15?s door for the treatment of type 2 diabetes mellitus

    TRENDS IN ENDOCRINOLOGY AND METABOLISM . 33(11): 741-754. Nº de citas: 22

    [doi:10.1016/j.tem.2022.08.004]

  • Espinosa-Jiménez T, Busquets O, Cano A, Sánchez-López E, Verdaguer E, Parcerisas A, Olloquequi J, Auladell C, Folch J, Wahli W, Vazquez M, Camins A and Ettcheto M.

    Peroxisomal Proliferator-Activated Receptor ß/d Deficiency Induces Cognitive Alterations.

    FRONTIERS IN PHARMACOLOGY . 13: 902047-902047. Nº de citas: 3

    [doi:10.3389/fphar.2022.902047]

  • Montori M, Aguilar-Recarte D, Zarei M, Pizarro J, Palomer FX and Vazquez M.

    Endoplasmic reticulum stress downregulates PGC-1a in skeletal muscle through ATF4 and an mTOR-mediated reduction of CRTC2

    CELL COMMUNICATION AND SIGNALING . 20(1): 53-53. Nº de citas: 14

    [doi:10.1186/s12964-022-00865-9]

  • Sepúlveda-Fragoso V, Alexandre-Santos B, Salles ACP, Proença AB, de Paula Alves AP, Vazquez M, da Nóbrega ACL, Frantz EDC and Magliano DC.

    Crosstalk between the renin-angiotensin system and the endoplasmic reticulum stress in the cardiovascular system: Lessons learned so far.

    LIFE SCIENCES . 284: 119919-119919. Nº de citas: 23

    [doi:10.1016/j.lfs.2021.119919]

  • García-Torra V, Cano A, Espina M, Ettcheto M, Camins A, Barroso E, Vazquez M, García ML, Sánchez-López E and Souto EB.

    State of the Art on Toxicological Mechanisms of Metal and Metal Oxide Nanoparticles and Strategies to Reduce Toxicological Risks.

    Toxics . 9(8): 195. Nº de citas: 22

    [doi:10.3390/toxics9080195]

  • Aguilar-Recarte D, Barroso E, Gumá L, Pizarro J, Peña L, Ruart M, Palomer FX, Wahli W and Vazquez M.

    GDF15 mediates the metabolic effects of PPARß/d by activating AMPK.

    CELL REPORTS . 36(6): 109501-109501. Nº de citas: 57

    [doi:10.1016/j.celrep.2021.109501]

  • Aguilar-Recarte D, Palomer FX, Wahli W and Vazquez M.

    The PPARß/d-AMPK Connection in the Treatment of Insulin Resistance.

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 22(16): 8555. Nº de citas: 21

    [doi:10.3390/ijms22168555]

  • Palomer FX, Aguilar-Recarte D, García R, Nistal JF and Vazquez M.

    Sirtuins: To Be or Not To Be in Diabetic Cardiomyopathy.

    TRENDS IN MOLECULAR MEDICINE . 27(6): 554-571. Nº de citas: 32

    [doi:10.1016/j.molmed.2021.03.004]

  • Codony S, Calvó-Tusell C, Valverde E, Osuna S, Morisseau C, Loza MI, Brea J, Pérez C, Rodríguez-Franco MI, Pizarro J, Corpas R, Griñán-Ferré C, Pallàs M, Sanfeliu C, Vazquez M, Hammock BD, Feixas F and Vázquez S.

    From the Design to the In Vivo Evaluation of Benzohomoadamantane-Derived Soluble Epoxide Hydrolase Inhibitors for the Treatment of Acute Pancreatitis.

    JOURNAL OF MEDICINAL CHEMISTRY . 64(9): 5429-5446. Nº de citas: 19

    [doi:10.1021/acs.jmedchem.0c01601]

  • Aguilar-Recarte D, Palomer FX and Vazquez M.

    Uncovering the role of apolipoprotein C-III in insulin resistance

    Clinica e Investigacion en Arteriosclerosis . 33(2): 108-115. Nº de citas: 5

    [doi:10.1016/j.arteri.2020.09.003]